Nathan Satter

Title: Nathan Satter: Innovator in Aortic Occlusion Devices

Introduction

Nathan Satter is a prominent inventor based in San Diego, CA, known for his contributions to medical device technology. He holds a total of 3 patents that focus on innovative solutions for aortic occlusion and embolic protection.

Latest Patents

Satter's latest patents include advanced aortic occlusion devices designed to enhance patient safety and treatment efficacy. These devices feature radially expandable and collapsible proximal and distal end portions, such as annular self-expanding stents or frames. They are specifically configured to radially expand within the aorta, securing the device in place. Additionally, the devices incorporate a catheter that extends axially between the distal and proximal end portions, along with a porous covering or filter. This filter is strategically positioned to capture emboli from blood flowing into upper-body arteries. Furthermore, the design includes a one-way valve located at or near the distal end portion, which restricts retrograde blood flow toward the heart.

Career Highlights

Nathan Satter is currently employed at Edwards Lifesciences Corporation, a leading company in the field of heart valve therapies and critical care monitoring. His work at Edwards Lifesciences has allowed him to focus on developing cutting-edge medical devices that improve patient outcomes.

Collaborations

Throughout his career, Satter has collaborated with notable colleagues, including Mark M Dehdashtian and Fabian Daniel Schroeder. These partnerships have contributed to the advancement of innovative medical technologies.

Conclusion

Nathan Satter's work in the field of aortic occlusion devices exemplifies his commitment to innovation in medical technology. His patents reflect a deep understanding of the complexities involved in cardiovascular health and demonstrate his dedication to improving patient care.